To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking Technology
Evidence-Based Complementary and Alternative Medicine · 2023-01 · 2023 (1)
DOI: 10.1155/2023/2827938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence-Based Complementary and Alternative Medicine, online erschienen am 16.02.2023. Verfasst von Fang Xu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Traditional Chinese Medicine, Kaifeng 475000, Henan, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, State Administration of Traditional Chinese Medicine of the People's Republic of China, Henan Provincial Science and Technology Research Project.
Abstract (Originalsprache)
Objective
In view of network pharmacology and molecular docking technology, to explore the targets as well as effect mechanism of the Huanglian Jiangtang formula (including Coptis chinensis , Anemarrhena asphodeloides , rhubarb wine, Cortex Moutan , Rehmannia glutinosa , and dried ginger ) in the type II diabetes therapy.
Methods
TCMSP and Batman database (DB) were used to retrieve the chemical components and action targets of drugs; GeneCards, OMIM, TTD, DrugBank, and other databases were applied to screen the disease targets. We used the UniProt DB to annotate the targets before building the drug‐compound‐target network with Cytoscape 3.9.1. We also exploited the String DB to construct the protein‐protein interaction (PPI) network. In addition, the targets for the treatment of type II diabetes were searched in the DrugBank, OMIM, GeneCards, and TTD database; then, we utilized Venn to intersect the key targets for the therapy of type II diabetes and active ingredient targets to obtain common targets. Furthermore, we exploited the common targets using GO and KEGG enrichment analysis method. The common targets and core components were analyzed by molecular docking using the AutoDock software.
Results
A total of 61 effective components of this compound were screened out; drugs and type II diabetes have 278 common targets; the PPI network screened core target proteins such as CDKN1A, CDK2, and E2F1 with the help of molecular docking technology; the three main compounds including quercetin, kaempferol, and gamma‐aminobutyric acid were obtained. Besides, the key target proteins had excellent binding properties with the main components. The signal pathways of six compound interventions in type II diabetes were mostly related to cancer, cocaine addiction, aminoacyl‐tRNA biosynthesis, glycine, serine, threonine metabolism, platinum drug resistance, and other pathways, according to the KEGG enrichment analysis method.
Conclusion
In the treatment of diabetes, the Huanglian Jiangtang formula has sorts of properties especially in the aspects of composition, target, and pathway. Its molecular target and mechanism of action may be related to pathways in cancer, cocaine addiction, aminoacyl‐tRNA biosynthesis, glycine, serine, threonine metabolism, platinum drug resistance, and other pathways. This conclusion can provide theoretical support and science for further research.
Autor:innen und Institutionen
- Hospital of Traditional Chinese Medicine, Kaifeng 475000, Henan, China.
- Nanjing University of Traditional Chinese Medicine, Nanjing 210023, Jiangsu, China.
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
ORCID-Profile: Fang Xu Li, Cheng Lu, Guoming Pang, Zhigang Lu
Förderung
- National Natural Science Foundation of China
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Li, F. X., Zhou, Z., Lu, C., Pang, G., & Lu, Z. (2023). To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking Technology. Evidence-Based Complementary and Alternative Medicine, 2023(1). https://doi.org/10.1155/2023/2827938
Vancouver
Li FX, Zhou Z, Lu C, Pang G, Lu Z. To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking Technology. Evidence-Based Complementary and Alternative Medicine. 2023;2023(1). doi:10.1155/2023/2827938
BibTeX
@article{Li2023,
author = {Li, Fang Xu and Zhou, Ziting and Lu, Cheng and Pang, Guoming and Lu, Zhigang},
title = {To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking Technology},
journal = {Evidence-Based Complementary and Alternative Medicine},
year = {2023},
volume = {2023},
number = {1},
doi = {10.1155/2023/2827938}
}
EUVIMED